中汽協:首八月汽車製造業實現利潤按年增速明顯回落 行業形勢嚴峻
中國汽車工業協會整理國家統計局公布數據顯示,2021年首八個月,汽車製造業實現利潤按年增速已回落至個位數,降幅明顯回落。
期內,汽車製造業累計實現利潤3,438.3億元人民幣(下同),按年增長5.5%,增速比1-7月回落14.2個百分點,增速均明顯低於同期規模以上企業及製造業,佔規模以上工業企業實現利潤總額的比重為6.1%,與1-7月相比繼續下降。
中汽協表示,在芯片短缺及原材料上漲雙重壓力下,自今年二季度以來,汽車製造業主要經濟效益指標增速及盈利水平均明顯回落,未來行業發展形勢比較嚴峻。(ta/u) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.